Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > So insulin needed?

<< Previous

Bullboard Posts

Next >>

Comment by elgin1on Jun 01, 2021 7:10pm

270 Views

Post# 33308149

RE:RE:RE:RE:RE:So insulin needed?

BioTeck wrote: I didn't sell everything. I sold a small portion of my shares (hawaii isn't that expensive). I also sold some and bought a cabin in the woods. If you hold everything you own forever, you'll never get to enjoy the fruits of your labor and it's also hard to dispose of a large quantity at once (as I'm sure you're aware of). I don't mind the sell and buy back (if warranted) technique, it has served me well like buying back in the 1.25-1.35 range.

Don't worry about me, I've done well and I'm more into enjoying the profits from over half a life of investments rather than to accumulate more.

Could not agree more . Nothing wrong in cashing in on profits . Sonny waited 10 years and was finally getting ready to enjoy some profits . You can never predict the future , live for today .

Anybody receive the circular for the AGM proxy yet ?

elgin1 wrote:

BioTeck wrote: We don't know what the reduction of insulin was for patient 1. 2 is 25, 3 is 40. If this trend continues as they fine tune the dosage with patients 4, 5, 6 and 7, we could be in pretty good shape.

Now if they could get their act together and release some info on Immunosuppression and any preclinical with the 2 pharma collaborations (if they have any pre clinical data yet), we'd be in amazing shape.

Depending on the results presented this weekend and the ones presented at the end of the month, I might consider keeping my shares for a little longer and see how things play out. In either case, I'll let you know once I've exited my position.

Bio,

I agree pat one was given portal vein top off who then became insulin free. Other patients have insulin reduction and perhaps a portal vein top off could result in insulin independence . But needless to say , having these types of results in brittle diabetics ( sickest of the sick) is extremely encouraging.

I do agree the competition is no where close which shoukd help for the time being.

As for you exiting your position , I guess we will hear from you in Hawaii last time you sold everything .....